EC Gynaecology

Pelvic Inflammatory Disease (PID) is a significant health issue that predominantly affects women of reproductive age. This condition, characterized by inflammation of the upper genital tract, can lead to serious complications such as chronic pelvic pain, infertility, and ectopic pregnancy, which may escalate into life-threatening situations. Among these complications, tubo-ovarian abscess (TOA) is particularly concerning, occurring in approximately 17% to 20% of PID cases [1-3].

 Keywords: Pelvic Inflammatory Disease; Cost-Effectiveness; Diagnosis; Treatment; Tubo-Ovarian Abscess

1. Golden N., et al. “The Use of Pelvic Ultrasonography in the Evaluation of Adolescents with Pelvic Inflammatory Disease”. American Journal of Diseases of Children11 (1987): 1235-1238.
2. Golden N., et al. “Pelvic Inflammatory Disease in Adolescents”. The Journal of Pediatrics1 (1989): 138-143.
3. Slap GB., et al. “Recognition of Tubo-Ovarian Abscess in Adolescents with Pelvic Inflammatory Disease”. The Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine6 (1996): 397-403.
4. Demirtas Omer., et al. “The Role of the Serum Inflammatory Markers for Predicting the Tubo-Ovarian Abscess in Acute Pelvic Inflammatory Disease: A Single-Center 5-Year Experience”. Archives of Gynecology and Obstetrics3 (2013): 519-523.
5. Ribak Rachel., et al. “Can the Need for Invasive Intervention in Tubo-Ovarian Abscess Be Predicted? The Implication of C-Reactive Protein Measurements”. Journal of Minimally Invasive Gynecology2 (2020): 541-547.
6. Savaris Ricardo F., et al. “Antibiotic Therapy for Pelvic Inflammatory Disease”. Cochrane Database of Systematic Reviews8 (2020): CD010285.
7. Parkin David. “Techniques of Economic Appraisal (including Cost-Effectiveness Analysis and Modelling, Cost-Utility Analysis, Option Appraisal and Cost-Benefit Analysis, the Measurement of Health Benefits in Terms of QALYs and Related Measures E.g. DALYs)”. Faculty of Public Health HealthKnowledge (2019).
8. Black WC. “The CE Plane: A Graphic Representation of Cost-Effectiveness”. Medical Decision Making: An International Journal of the Society for Medical Decision Making 3 (1990): 212-214.